DMII (Drugs Made In America Acquisition II) Other Long Term Assets: $509.37 Mil (As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Other Long Term Assets?

Drugs Made In America Acquisition II DMII 15 Other Long Term Assets is $509.37 Mil as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Drugs Made In America Acquisition II's other long-term assets for the quarter that ended in Mar. 2026 was $509.37 Mil.

Drugs Made In America Acquisition II's quarterly other long-term assets increased from Sep. 2025 ($500.11 Mil) to Dec. 2025 ($504.93 Mil) and increased from Dec. 2025 ($504.93 Mil) to Mar. 2026 ($509.37 Mil).

Drugs Made In America Acquisition II's annual other long-term assets increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.08 Mil) and increased from Dec. 2024 ($0.08 Mil) to Dec. 2025 ($504.93 Mil).

Drugs Made In America Acquisition II Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Other Long Term Assets Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Other Long Term Assets
0.08 504.93

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long Term Assets Get a 7-Day Free Trial 0.09 0.10 500.11 504.93 509.37
DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $509.37 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Other Long Term Assets of $509.37 Mil as of Mar. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Other Long Term Assets too high?
Drugs Made In America Acquisition II's current Other Long Term Assets is $509.37 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Other Long Term Assets compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Other Long Term Assets of $509.37 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Diversified Financial Services company?
A good Other Long Term Assets depends on the Diversified Financial Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Other Long Term Assets is $509.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Other Long Term Assets of $509.37 Mil. The current Other Long Term Assets is $509.37 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Other Long Term Assets is $509.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price